Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Devogelaer

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Current Opinion in Rheumatology|July 26, 2000
Treatment of bone diseases with bisphosphonates, excluding osteoporosisJ P Devogelaer
Current Opinion in Rheumatology|July 1, 1996
Clinical use of bisphosphonatesJ P Devogelaer
Bailliere'S Clinical Rheumatology|August 1, 1997
How do you know who needs prevention or treatment?J P Devogelaer
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Long-lasting effect of pamidronate on bone metabolism in osteoporosis after stopping therapyJ P Devogelaer
Drug Safety|August 15, 1998
A risk-benefit assessment of alendronate in the treatment of involutional osteoporosisJ P Devogelaer
Transplantation Proceedings|September 27, 2005
Bone disorders after organ transplantationE Goffin, J-P Devogelaer
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 1, 2003
Does peripheral quantitative computed tomography ignore tissue density of cancellous bone?X Banse, J P Devogelaer
Revue Medicale De Liege|January 14, 2005
[Treatment of postmenopausal osteoporosis in 2004]J Y Reginster, J P Devogelaer
Clinical Rheumatology|September 1, 1995
Fluoride therapy of type I osteoporosisJ P Devogelaer, C Nagant de Deuxchaisnes
British Journal of Rheumatology|June 1, 1993
OsteoporosisJ P Devogelaer, C Nagant de Deuxchaisnes
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Current Opinion in Rheumatology|July 26, 2000
Treatment of bone diseases with bisphosphonates, excluding osteoporosisJ P Devogelaer
Current Opinion in Rheumatology|July 1, 1996
Clinical use of bisphosphonatesJ P Devogelaer
Bailliere'S Clinical Rheumatology|August 1, 1997
How do you know who needs prevention or treatment?J P Devogelaer
Journal of Musculoskeletal & Neuronal Interactions|March 11, 2005
Long-lasting effect of pamidronate on bone metabolism in osteoporosis after stopping therapyJ P Devogelaer
Drug Safety|August 15, 1998
A risk-benefit assessment of alendronate in the treatment of involutional osteoporosisJ P Devogelaer
Transplantation Proceedings|September 27, 2005
Bone disorders after organ transplantationE Goffin, J-P Devogelaer
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|April 1, 2003
Does peripheral quantitative computed tomography ignore tissue density of cancellous bone?X Banse, J P Devogelaer
Revue Medicale De Liege|January 14, 2005
[Treatment of postmenopausal osteoporosis in 2004]J Y Reginster, J P Devogelaer
Clinical Rheumatology|September 1, 1995
Fluoride therapy of type I osteoporosisJ P Devogelaer, C Nagant de Deuxchaisnes
British Journal of Rheumatology|June 1, 1993
OsteoporosisJ P Devogelaer, C Nagant de Deuxchaisnes
Pageof 14